V Young1, M Ho, H Vosper, J J F Belch, C N A Palmer. 1. Biomedical Research Centre, Department of Medicine, Ninewells Hospital and Medical School, University of Dundee, UK.
Abstract
OBJECTIVE: To determine the expression of molecular markers of prostanoid/fatty acid signalling in leucocytes of patients with systemic sclerosis (SSc). METHODS: Gene expression in patient leucocytes was analysed using real-time fluorescence reverse transcriptase polymerase chain reaction for tumour necrosis factor alpha (TNF-alpha), thromboxane synthase (TXAS, CYP5A), prostacyclin synthase (CYP8A), monocyte chemoattractant protein-1 (MCP-1), peroxisome proliferator-activated receptors (PPAR) alpha, delta and gamma, low-density lipoprotein-associated lipoprotein lipase A(2) (LDL-PLA(2)), apolipoprotein E (apoE) and cholesterol 27-hydroxylase (CYP27). RESULTS: Both TNF-alpha and TXAS showed an increase in mean expression in the diseased group (6.3-fold and 5.6-fold respectively, P<0.0001). These two markers, along with CYP27, PPARgamma and apoE, provided predictive markers for the development of carotid artery disease within the SSc patient population. CONCLUSION: The elevated levels of TNF-alpha and thromboxane seen in SSc patient sera are paralleled by increases in the expression of the appropriate genes in leucocytes. This method will allow us to screen for a large number of candidate markers of disease in order to increase our understanding of the processes underlying the pathology of SSc.
OBJECTIVE: To determine the expression of molecular markers of prostanoid/fatty acid signalling in leucocytes of patients with systemic sclerosis (SSc). METHODS: Gene expression in patient leucocytes was analysed using real-time fluorescence reverse transcriptase polymerase chain reaction for tumour necrosis factor alpha (TNF-alpha), thromboxane synthase (TXAS, CYP5A), prostacyclin synthase (CYP8A), monocyte chemoattractant protein-1 (MCP-1), peroxisome proliferator-activated receptors (PPAR) alpha, delta and gamma, low-density lipoprotein-associated lipoprotein lipase A(2) (LDL-PLA(2)), apolipoprotein E (apoE) and cholesterol 27-hydroxylase (CYP27). RESULTS: Both TNF-alpha and TXAS showed an increase in mean expression in the diseased group (6.3-fold and 5.6-fold respectively, P<0.0001). These two markers, along with CYP27, PPARgamma and apoE, provided predictive markers for the development of carotid artery disease within the SSc patient population. CONCLUSION: The elevated levels of TNF-alpha and thromboxane seen in SSc patient sera are paralleled by increases in the expression of the appropriate genes in leucocytes. This method will allow us to screen for a large number of candidate markers of disease in order to increase our understanding of the processes underlying the pathology of SSc.
Authors: José Alvaro Lomelí-Nieto; José Francisco Muñoz-Valle; Christian Johana Baños-Hernández; José Eduardo Navarro-Zarza; María Guadalupe Ramírez-Dueñas; Pedro Ernesto Sánchez-Hernández; Andrea Carolina Machado-Sulbaran; Isela Parra-Rojas; Mariel García-Chagollán; Jorge Hernández-Bello Journal: Clin Exp Med Date: 2019-07-29 Impact factor: 3.984
Authors: Joanna Kosałka-Węgiel; Sabina Lichołai; Sylwia Dziedzina; Mamert Milewski; Piotr Kuszmiersz; Anna Rams; Jolanta Gąsior; Aleksandra Matyja-Bednarczyk; Helena Kwiatkowska; Mariusz Korkosz; Andżelika Siwiec; Paweł Koźlik; Agnieszka Padjas; Wojciech Sydor; Jerzy Dropiński; Marek Sanak; Jacek Musiał; Stanisława Bazan-Socha Journal: Life (Basel) Date: 2022-05-07
Authors: Larry G Higgins; Wojciech G Garbacz; Mattias C U Gustafsson; Sitheswaran Nainamalai; Peter R Ashby; C Roland Wolf; Colin N A Palmer Journal: PPAR Res Date: 2012-03-21 Impact factor: 4.964